Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis: A Community Study

NCT04899180 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04899180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04899180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis: A Community Study
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
July 14, 2023
Completion date
January 5, 2024
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, transthyretin amyloid cardiomyopathy, transthyretin amyloidosis, transthyretin cardiac amyloidosis